- Illustrations
- Specialized Illustrations
- Progression of Fetal Growth at Week 19
Progression of Fetal Growth at Week 19
A closer glimpse of the fetus at Gestational Week Nineteen into focus, defining the refined contours of the face.
jpg, png
exc.VAT*
Prices are displayed excluding VAT. VAT will be calculated during checkout based on your business location and VAT number validity.
Description
Curled in a typical flexed fetal posture, the conceptus at gestational week 19 is shown suspended within the amniotic cavity, with the craniofacial profile oriented anteriorly and the limbs drawn toward the trunk. Fine facial contours are evident, including the closed palpebral fissures, external auricles, and a more defined nasal bridge and mandible, while the skin remains relatively translucent compared with term. Superior and lateral to the fetus, the placenta apposes the uterine wall, and the umbilical cord courses from the fetal umbilicus to the chorionic plate, its paired umbilical arteries spiraling around the single umbilical vein. Week 19 sits in the mid-second trimester, when biometric assessment and screening commonly rely on ultrasound correlation of anatomy that is now proportioned enough to measure but still changing rapidly. This view supports teaching and counseling around placental location and cord insertion, topics that intersect with placenta previa evaluation and the recognition of marginal or velamentous cord insertion as risk factors for fetal growth restriction and vasa previa. The prominent cord vasculature also reinforces why Doppler interrogation of the umbilical artery becomes clinically informative when placental insufficiency is suspected. A brief, readable snapshot. Use this asset in embryology and obstetrics teaching modules, second-trimester anatomy survey references, patient education materials explaining placental function and the umbilical cord, and medical publishing layouts that need a realistic 3D fetus-in-utero context against a clean black background. Anatomical accuracy verified by SciePro's Medical Advisory Board.